Patent classifications
A61B10/0041
Spectrometric analysis of microbes
A method of analysis using mass spectrometry and/or ion mobility spectrometry is disclosed. The method comprises: using a first device to generate smoke, aerosol or vapour from a target comprising or consisting of a microbial population; mass analysing and/or ion mobility analysing said smoke, aerosol or vapour, or ions derived therefrom, in order to obtain spectrometric data; and analysing said spectrometric data in order to analyse said microbial population.
Multimodal system for breast imaging
A multimodal system for breast imaging includes an x-ray source, and an x-ray detector configured to detect x-rays from the x-ray source after passing through a breast. The system includes an x-ray detector translation system operatively connected to the x-ray detector so as to be able to translate the x-ray detector from a first displacement from the breast to a second displacement at least one of immediately adjacent to or in contact with the breast. The system includes an x-ray image processor configured to: receive a CT data set from the x-ray detector, the CT data set being detected by the x-ray detector at the first displacement; compute a CT image of the breast; receive a mammography data set from the x-ray detector, the mammography data set being detected by the x-ray detector at the second displacement; and compute a mammography image of the breast.
ULTRAFINE NEEDLE ENDOSCOPE APPARATUS FOR DEEP INTERSTITIAL EXAMINATION BY WHITE LIGHT IMAGING, AUTOFLUORESCENCE IMAGING AND RAMAN SPECTROSCOPY
Endoscope apparatuses for generating at least one image of a portion of an object are described herein. The endoscope apparatus includes an ultrafine needle adapted for insertion into the object; a fiber probe that is slidably disposed in the ultrafine needle, the fiber probe including a plurality of optical fibers or cores that act as illumination optical fibers and collection optical fibers; an optical assembly that is coupled to the fiber probe, the optical assembly including: at least one transmission optical pathway to provide at least one excitation light signal to the portion of the object to be imaged during use; and at least one return optical pathway that is adapted to transmit reflected light signals from the portion of the object when it is illuminated during use with at least one sensor for generating at least one image via at least one set of optical elements.
MARKER DELIVERY DEVICE WITH PUSH ROD HAVING ACTUATION FEATURES
A marker delivery device includes a housing, a flexible push rod, and a wheel. The push rod includes a first transverse dive surface and a deployer tip. The deployer tip is configured to receive a biopsy site marker. The wheel includes a second transverse drive surface. The first transverse drive surface is configured to be driven by the second transverse drive surface to translate the push rod distally.
Medical imaging device and methods of use
Embodiments related to medical imaging devices including rigid imaging tips and their methods of use for identifying abnormal tissue within a surgical bed are disclosed.
Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith
The present invention relates to intraoperative fluorescent imaging (IFI) used both pre-clinically using in-vivo models, as well as clinically to map sentinel lymph nodes in breast cancer, skin cancer, GI cancer, lung cancer, prostate cancer and several other cancers. IFI can be used to image solid tumors both non-specifically in hepatobiliary and breast cancers as well as in prostate and ovarian cancer. In one embodiment, two-dimensional resolution to 10 μm.sup.2 is possible with optical imaging, significantly higher than other imaging modalities. In one embodiment, the present invention relates to a series of self-assembled nanoparticles using HLA (hyaluronic acid) as both a polymeric backbone as well as targeting ligand. In some embodiments, the present invention relates to the synthesis of HLA conjugates, and the effect of variation of the hydrophobic ligand structure and conjugation level on nanoparticle self-assembly, size, ICG loading efficiency, and ICG fluorescence quenching and reactivation.
MULTIMODAL SYSTEM FOR BREAST IMAGING
A multimodal system for breast imaging includes an x-ray source, and an x-ray detector configured to detect x-rays from the x-ray source after passing through a breast. The system includes an x-ray detector translation system operatively connected to the x-ray detector so as to be able to translate the x-ray detector from a first displacement from the breast to a second displacement at least one of immediately adjacent to or in contact with the breast. The system includes an x-ray image processor configured to: receive a CT data set from the x-ray detector, the CT data set being detected by the x-ray detector at the first displacement; compute a CT image of the breast; receive a mammography data set from the x-ray detector, the mammography data set being detected by the x-ray detector at the second displacement; and compute a mammography image of the breast.
APPARATUS, SYSTEMS AND METHODS FOR IN VIVO IMAGING
The disclosed apparatus, systems and methods relate to the use of optical nanoparticles in the illumination and imaging of tissues such as cancer tissues. Optical nanoparticles such as upconverting nanoparticles can be introduced into a patient and illuminated at a first time and wavelength and then imaged at a second time and wavelength to improve resolution and reduce imager size.
METHOD AND SYSTEM FOR DELINEATING AND LINKING/CORRELATING OPPOSING MARGINS OF A PATHOLOGY SPECIMEN AND IMMEDIATELY ADJACENT REMAINING IN VIVO MARGINS
The disclosure is directed to a novel technique for anatomically orientating a removed tissue specimen with the margins of the tissue from which it has been removed. An example process of marking the margins of the excised surgical specimen and the anatomically adjacent in vivo margins can be implemented by a surgeon at the time of removal of the surgical specimen. After removing the surgical specimen from its adjacent tissue, a surgical cavity is generated. Thereafter, locations around the surface margins of the specimen and appropriate locations on the margins of the surgical cavity are marked with one or more pairs of markers (SpM and IVM respectively) with matching identities.
SPECTROMETRIC ANALYSIS OF MICROBES
A method of analysis using mass spectrometry and/or ion mobility spectrometry is disclosed. The method comprises: using a first device to generate smoke, aerosol or vapour from a target comprising or consisting of a microbial population; mass analysing and/or ion mobility analysing said smoke, aerosol or vapour, or ions derived therefrom, in order to obtain spectrometric data; and analysing said spectrometric data in order to analyse said microbial population.